|
Volumn 9, Issue 5, 2006, Pages 383-387
|
Efficacy and safety of adjuvant post-surgical therapy with imatinib in gastrointestinal stromal tumor patients with high risk of recurrence: interim analysis from a multicenter prospective clinical trial
a a a a a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
IMATINIB;
PIPERAZINE DERIVATIVE;
PYRIMIDINE DERIVATIVE;
ADJUVANT CHEMOTHERAPY;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
FEMALE;
GASTROINTESTINAL STROMAL TUMOR;
HUMAN;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
POSTOPERATIVE PERIOD;
PROSPECTIVE STUDY;
TUMOR RECURRENCE;
ADULT;
AGED;
AGED, 80 AND OVER;
CHEMOTHERAPY, ADJUVANT;
FEMALE;
GASTROINTESTINAL STROMAL TUMORS;
HUMANS;
MALE;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
PIPERAZINES;
POSTOPERATIVE PERIOD;
PROSPECTIVE STUDIES;
PYRIMIDINES;
YOUNG ADULT;
|
EID: 34248190431
PISSN: 16710274
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (13)
|
References (0)
|